New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Acumen Pharmaceuticals, Inc.
ABOS
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

162M

Biotechnology

Next Earning date - 11 Nov 2024

162M

Biotechnology

Next Earning date - 11 Nov 2024

2.70USD
Shape-0.16 ( -5.59%)
favorite-chart

Relative Strenght

13
favorite-chart

Volume Buzz

-18%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

47%

Quote Panel

Shape
Updated October 21, 2024
1W 15.88 % 1M 13.92 % 3M -16.41 % 1Y -18.43 %

Key Metrics

Shape
  • Market Cap

    162.22M


  • Shares Outstanding

    60.08M


  • Share in Float

    45.03M


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    2.7


  • Average Volume

    220710


  • Beta

    0.072


  • Range

    1.81-5.09


  • Industry

    Biotechnology


  • Website

    https://acumenpharm.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

557.29x

P/S Ratio

0.66x

P/B Ratio

0.1

Debt/Equity

-22366.9%

Net Margin

$-1.1

EPS

How ABOS compares to sector?

P/E Ratio

Relative Strength

Shape

ABOS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape
0

$1.54

Shape-352%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Citigroup

initialise

Previous: Not converted

2024-07-25

Now: Buy

BTIG

initialise

Previous: Not converted

2023-05-18

Now: Buy

Jefferies

initialise

Previous: Not converted

2023-05-18

Now: Hold

Scotiabank

initialise

Previous: Not converted

2023-05-18

Now: Sector Perform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.26
vs -0.10

Q4.22

arrow
arrow

N/A

-0.32
vs -0.42

Q1.23

arrow
arrow

N/A

-0.28
vs -0.23

Q2.23

arrow
arrow

N/A

-0.28
vs -0.25

Q3.23

arrow
arrow

N/A

-0.24
vs -0.26

Q4.23

arrow
arrow

N/A

-0.29
vs -0.32

Q1.24

arrow
arrow

N/A

-0.25
vs -0.28

Q2.24

arrow
arrow

N/A

-0.34
vs -0.28

Q3.24

arrow
arrow

N/A

-0.36
vs -0.24

Q4.24

arrow
arrow

N/A

-0.39
vs -0.29

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

290K  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-5%

-0.05
vs -0.05

Q4.22

arrow
arrow

-7%

-0.07
vs -0.05

Q1.23

arrow
arrow

-5%

-0.05
vs -0.07

Q2.23

arrow
arrow

-7%

-0.07
vs -0.05

Q3.23

arrow
arrow

-5%

-0.05
vs -0.07

Q4.23

arrow
arrow

-6%

-0.06
vs -0.05

Q1.24

arrow
arrow

-6%

-0.06
vs -0.06

Q2.24

arrow
arrow

-8%

-0.08
vs -0.06

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

56

56
vs 46

22%

Q4.22

arrow
arrow

65

65
vs 56

16%

Q1.23

arrow
arrow

65

65
vs 65

NA

Q2.23

arrow
arrow

60

60
vs 65

-8%

Q3.23

arrow
arrow

73

73
vs 60

22%

Q4.23

arrow
arrow

72

72
vs 73

-1%

Q1.24

arrow
arrow

84

84
vs 72

17%

Q2.24

arrow
arrow

86

86
vs 84

2%

Earnings Growth

Latest News